Importantly, we discovered the decreased expression of ZO-1 protein in the intestine of MPTP-treated mice via immunofluorescence and immunoblotting, suggesting the damaged intestinal barrier function in the gut-brain axis of PD mice. This evidence concerns the gene TJP1 and Parkinson disease.